ArticleDiabetology & metabolic syndrome2018
To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study".
Florian J Mayer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.